(Q33350235)

English

Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2 references

13 March 2019

27 January 2021

Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

anxiety disorder

1 reference

13 March 2019

major depressive disorder

2 references

13 March 2019

27 January 2021

obsessive-compulsive disorder

1 reference

13 March 2019

1 reference

based on heuristic

inferred from title

author name string

David Cohen

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Emmanuelle Deniau

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alejandro Maturana

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marie-Laure Tanguy

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nicolas Bodeau

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Réal Labelle

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jean-Jacques Breton

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jean-Marc Guile

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

9 July 2008

3 references

Europe PubMed Central

PubMed publication ID

26 July 2017

13 March 2019

27 January 2021

3 references

Europe PubMed Central

PubMed publication ID

26 July 2017

13 March 2019

27 January 2021

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

e2632

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

copyright license

Creative Commons Attribution 4.0 International

2 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

27 January 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

A systematic review of placebo response in studies of bipolar mania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Efficacy and safety of antidepressants for children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Antidepressants for generalised anxiety disorder (GAD)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Placebo effect in randomized, controlled studies of acute bipolar mania and depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Efficacy of interpersonal psychotherapy for depressed adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Adolescent depression: controlled desipramine treatment and atypical features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Childhood and adolescent depression: a review of the past 10 years. Part I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Object relations theory and pharmacopsychotherapy of anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Behavioural inhibition, attachment and anxiety in children of mothers with anxiety disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Psychosocial interventions for adolescent depression: issues, evidence, and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

School phobia: a therapeutic trial with clomipramine and short-term outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

School phobia: diagnostic considerations in the light of imipramine effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Know thyself--adolescents' self-assessment of compliance behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Imipramine in prepubertal major depressive disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Depressive disorders in childhood. IV. A longitudinal study of comorbidity with and risk for anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Noncompliance in adolescents: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

The effect of concomitant disorders in childhood depression on predicting treatment response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Baseline and 2- to 3-year follow-up characteristics of placebo-washout responders from the nortriptyline study of depressed 6- to 12-year-olds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

21 June 2018

Phenomenology, psychosocial correlates, and treatment seeking in major depression and dysthymia of adolescence

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Differences in early childhood risk factors for juvenile-onset and adult-onset depression.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Pharmacological treatment of adolescent major depression

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

A two-year follow-up of psychodynamic psychotherapy for internalizing disorders in children.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Suicidality in pediatric patients treated with antidepressant drugs

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Incorporating variations in the quality of individual randomized trials into meta-analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Treatment for Adolescents With Depression Study (TADS): Rationale, Design, and Methods

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Long-term sertraline treatment of children and adolescents with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Stressful life events in anxious and depressed children

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Analog classroom assessment of Adderall in children with ADHD.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Fluoxetine for the treatment of childhood anxiety disorders

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0002632

21 January 2018

Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2435626

31 October 2018

Child and adolescent nortriptyline single dose pharmacokinetic parameters: final report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine plus cognitive-behavioral therapy in the treatment of school refusal

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression in children: relationship between plasma imipramine levels and response

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine compliance in adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychological factors associated with medication nonadherence in asthmatic children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine treatment of depressed children: a double-blind pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of depression in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venlafaxine in the treatment of children and adolescents with major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression in prepubertal children: dexamethasone nonsuppression predicts differential response to imipramine vs. placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effects of amitriptyline in adolescent depression. A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative studies of pharmacotherapy for school refusal

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline in children and adolescents with major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood obsessive-compulsive disorder: a prospective follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine vs. placebo studies of childhood depression: baseline predictors of response to treatment and factor analysis of presenting symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to desipramine treatment in adolescent major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonazepam in childhood anxiety disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine treatment of children with separation anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amitriptyline in children with major depressive disorder: a double-blind crossover pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0002632

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2008PLoSO...3.2632C

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33350235&oldid=1991134023"